BusinessCascadian Therapeutics to Report Third Quarter 2017 Financial Results on November 8, 2017By Nasdaq OMXNov 1, 2017, 1:19 PM UTC
BusinessBeyondSpring Announces the First Patient Enrolled in China in its Global Phase 2/3 Trial with Plinabulin for the Prevention of Chemotherapy-Induced NeutropeniaBy Nasdaq OMXOct 26, 2017, 12:31 PM UTC
BusinessCascadian Therapeutics to Participate in Panel Discussions at Two Conferences in NovemberBy Nasdaq OMXOct 24, 2017, 12:05 PM UTC
BusinessBeyondSpring Receives Two Grants in China to Further Develop Innovative Drug PipelineBy Nasdaq OMXOct 23, 2017, 12:31 PM UTC
BusinessBeyondSpring Chief Medical Officer to Present at the 2017 BIO Investor Forum on Oct. 18 in San FranciscoBy Nasdaq OMXOct 18, 2017, 12:30 PM UTC
BusinessIGC-AD1 Targeting Alzheimer’s Disease to be commercialized in early 2018 Through Medical DispensariesBy Nasdaq OMXOct 18, 2017, 12:01 PM UTC
BusinessClinipace Worldwide Co-founder & CEO Jeff Williams to Resign as CEOBy Nasdaq OMXOct 17, 2017, 1:49 PM UTC
BusinessPresident John Lai Discusses Current Auditing State, the New Kush Product and the Company’s New AdditionsBy Nasdaq OMXSep 28, 2017, 1:30 PM UTC
